Probably Genetic hopes to provide families of children on the autism spectrum with more complete diagnoses.
Venture capitalists are pouring hundreds of millions of dollars into healthcare startups pitching lower-cost alternatives to traditional services, and one of their primary targets is diagnostics. As i
Welcome to the future… where startups are willing to customize everything from a diet regimen to a workout plan, or family planning to personal fashion based on an individual’s genetic c
Prenetics, a genetic testing startup, plans to expand into more Asian countries after raising a $40 million Series B led by Beyond Ventures and Alibaba Hong Kong Entrepreneurs Fund.
The company first began making moves early in 2015, forging a partnership with Pfizer to conduct a bit of drug research using 23andMe’s genetic data. The pact was formed in the midst of orders f
Cancer and heart disease are the two leading causes of death in the United States. So far, Color Genomics has been focused on testing for mutations leading to a higher risk of certain cancers. But, to
Genoox, a startup that wants to make it easier for medical professionals to use genomic data in patient care, has raised $6 million in funding. The capital includes a seed round from Inimiti Capital P
The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, includi
One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99
Want to know if you have the “athlete gene” or if you’re actually related to the weirdos who claim you as a family member? Get your collection tubes ready, citizen scientists, Bento
Things are looking up for 23andMe. Right off a fresh $115 million cash infusion, the Food and Drug Administration is giving the direct-to-consumer DNA company the green light to include health and c
After the Food and Drug Administration ordered that 23andMe suspend use of its at-home gene testing kits, based on the government organization's belief that it constitutes a medical device and thus re
The U.S. Food and Drug Administration has ordered 23andMe, the genomic startup co-founded by Anne Wojcicki, Linda Avey and Paul Cusenza in 2006, to stop selling its at-home DNA testing kits as of Nove